![Study of PrEP and vaginal ring for HIV prevention begins in girls and young women | National Institutes of Health (NIH) Study of PrEP and vaginal ring for HIV prevention begins in girls and young women | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/styles/featured_media_breakpoint-medium/public/news-events/news-releases/2019/20190207-niaid-ring-truvada.jpg?itok=-3P_HV7D×tamp=1549487293)
Study of PrEP and vaginal ring for HIV prevention begins in girls and young women | National Institutes of Health (NIH)
![Safety, Acceptability and Pharmacokinetic Assessment (Adherence) of Monthly Dapivirine Vaginal Microbicide Rings (Ring-004) for HIV Prevention Safety, Acceptability and Pharmacokinetic Assessment (Adherence) of Monthly Dapivirine Vaginal Microbicide Rings (Ring-004) for HIV Prevention](https://www.natap.org/2012/images/051412/051412-1/EASL2.gif)
Safety, Acceptability and Pharmacokinetic Assessment (Adherence) of Monthly Dapivirine Vaginal Microbicide Rings (Ring-004) for HIV Prevention
![High Use and Adherence Seen With Dapivirine Vaginal Ring for HIV Prevention - Infectious Disease Advisor High Use and Adherence Seen With Dapivirine Vaginal Ring for HIV Prevention - Infectious Disease Advisor](https://www.infectiousdiseaseadvisor.com/wp-content/uploads/sites/16/2019/01/vaginalringshutterstock17152_1266804.jpg)
High Use and Adherence Seen With Dapivirine Vaginal Ring for HIV Prevention - Infectious Disease Advisor
![Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study - The Lancet HIV Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study - The Lancet HIV](https://www.thelancet.com/cms/asset/7b4d3644-044a-42c4-8596-138cc2ac5e2a/gr1.jpg)
Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study - The Lancet HIV
![WHO continues to support its conditional recommendation for the dapivirine vaginal ring as an additional prevention option for women at substantial risk of HIV WHO continues to support its conditional recommendation for the dapivirine vaginal ring as an additional prevention option for women at substantial risk of HIV](https://www.who.int/images/default-source/departments/hiv/ring_two-hands-(credit---andrew-loxley-courtesy-of-ipm)_small.jpg?sfvrsn=d564fe71_7)
WHO continues to support its conditional recommendation for the dapivirine vaginal ring as an additional prevention option for women at substantial risk of HIV
![Study suggests dapivirine vaginal ring is safe to use as HIV prevention during breastfeeding | Department of Epidemiology Study suggests dapivirine vaginal ring is safe to use as HIV prevention during breastfeeding | Department of Epidemiology](https://epi.washington.edu/wp-content/uploads/2023/02/ring-2.jpeg)
Study suggests dapivirine vaginal ring is safe to use as HIV prevention during breastfeeding | Department of Epidemiology
![Consistent Use of Dapivirine Vaginal Ring Could Offer More Than 75% HIV Protection, New Data Suggests Consistent Use of Dapivirine Vaginal Ring Could Offer More Than 75% HIV Protection, New Data Suggests](https://images.ctfassets.net/pdtztwrkphaf/tbart_promo_tb_78094_image_image/89413dee806bb4be3e6f42cca81f74b0/vaginal_ring_200x200.jpg?w=1200&fm=jpg&fit=thumb&q=65&fl=progressive)
Consistent Use of Dapivirine Vaginal Ring Could Offer More Than 75% HIV Protection, New Data Suggests
![How the vaginal ring for HIV prevention that has been approved for use by women above 18 in SA works | Drum How the vaginal ring for HIV prevention that has been approved for use by women above 18 in SA works | Drum](https://cdn.24.co.za/files/Cms/General/d/1773/919d1ce0f5ec407683420bb4ec7eb73b.jpg)